DK472688D0 - Anvendelse af bezafibrat til behandling af diabetes - Google Patents

Anvendelse af bezafibrat til behandling af diabetes

Info

Publication number
DK472688D0
DK472688D0 DK472688A DK472688A DK472688D0 DK 472688 D0 DK472688 D0 DK 472688D0 DK 472688 A DK472688 A DK 472688A DK 472688 A DK472688 A DK 472688A DK 472688 D0 DK472688 D0 DK 472688D0
Authority
DK
Denmark
Prior art keywords
bezafibrate
treat diabetes
diabetes
treat
normolipidaemic
Prior art date
Application number
DK472688A
Other languages
English (en)
Other versions
DK472688A (da
Inventor
Walter Beck
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of DK472688D0 publication Critical patent/DK472688D0/da
Publication of DK472688A publication Critical patent/DK472688A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK472688A 1987-09-01 1988-08-24 Anvendelse af bezafibrat til behandling af diabetes DK472688A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873729209 DE3729209A1 (de) 1987-09-01 1987-09-01 Verwendung von bezafibrat zur behandlung von diabetes

Publications (2)

Publication Number Publication Date
DK472688D0 true DK472688D0 (da) 1988-08-24
DK472688A DK472688A (da) 1989-03-02

Family

ID=6334986

Family Applications (1)

Application Number Title Priority Date Filing Date
DK472688A DK472688A (da) 1987-09-01 1988-08-24 Anvendelse af bezafibrat til behandling af diabetes

Country Status (16)

Country Link
US (1) US5304575A (da)
EP (1) EP0305890B1 (da)
JP (1) JP2647918B2 (da)
KR (1) KR890004690A (da)
AT (1) ATE95694T1 (da)
AU (1) AU610228B2 (da)
CA (1) CA1323575C (da)
DE (2) DE3729209A1 (da)
DK (1) DK472688A (da)
ES (1) ES2059457T3 (da)
HU (1) HU200687B (da)
IE (1) IE62189B1 (da)
IL (1) IL87566A0 (da)
PH (1) PH24568A (da)
PT (1) PT88383B (da)
ZA (1) ZA886459B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US7115728B1 (en) * 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
WO1998005331A2 (en) * 1996-08-02 1998-02-12 Ligand Pharmaceuticals Incorporated Prevention or treatment of type 2 diabetes or cardiovascular disease with ppar modulators
WO1999005161A1 (en) * 1997-07-25 1999-02-04 Ligand Pharmaceuticals Incorporated HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARη) GENE REGULATORY SEQUENCES AND USES THEREFOR
FR2774591B1 (fr) * 1998-02-12 2000-05-05 Lipha Composition pharmaceutique comprenant l'association metformine et fibrate et son utilisation pour la preparation de medicaments destines a reduire l'hyperglycemie
JP4879433B2 (ja) 2000-01-13 2012-02-22 エミスフェアー・テクノロジーズ・インク 活性剤を送達するための化合物および組成物
BR0307727A (pt) 2002-02-20 2005-01-25 Lilly Co Eli Fomulação
US7264813B2 (en) 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
US20060286129A1 (en) * 2003-12-19 2006-12-21 Emisphere Technologies, Inc. Oral GLP-1 formulations
EP1714648A4 (en) * 2004-02-09 2010-05-26 Aska Pharm Co Ltd COMBINATION DRUGS
FR2898894B1 (fr) * 2006-03-24 2008-06-06 Genfit Sa Composes derives de n-(phenethyl)benzamide substitues, preparation et utilisations
US10098860B2 (en) 2016-07-20 2018-10-16 Cipla Limited Bezafibrate for the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2149070C3 (de) * 1971-10-01 1978-03-23 Boehringer Mannheim Gmbh, 6800 Mannheim Phenoxyalkylcarbonsäurederivate und deren Salze, Verfahren zu deren Herstellung und Arzneimittel
JPS56145261A (en) * 1980-04-10 1981-11-11 Kaken Pharmaceut Co Ltd Novel oxyacetic acid derivative, its preparation, and lowering agent of lipid in blood comprising it as active ingredient

Also Published As

Publication number Publication date
AU2158688A (en) 1989-05-25
ATE95694T1 (de) 1993-10-15
CA1323575C (en) 1993-10-26
PT88383A (pt) 1989-07-31
JP2647918B2 (ja) 1997-08-27
AU610228B2 (en) 1991-05-16
IL87566A0 (en) 1989-01-31
EP0305890A2 (de) 1989-03-08
ZA886459B (en) 1989-05-30
DK472688A (da) 1989-03-02
PT88383B (pt) 1992-10-30
HU200687B (en) 1990-08-28
DE3884895D1 (de) 1993-11-18
IE62189B1 (en) 1994-12-28
IE882529L (en) 1989-03-01
ES2059457T3 (es) 1994-11-16
DE3729209A1 (de) 1989-03-09
EP0305890B1 (de) 1993-10-13
JPS6471813A (en) 1989-03-16
HUT47427A (en) 1989-03-28
DE3729209C2 (da) 1989-08-03
KR890004690A (ko) 1989-05-09
US5304575A (en) 1994-04-19
EP0305890A3 (en) 1990-08-22
PH24568A (en) 1990-08-03

Similar Documents

Publication Publication Date Title
DE69028542D1 (de) Felbamat zur Behandlung der Lennox-Gastaut syndrome
DK472688D0 (da) Anvendelse af bezafibrat til behandling af diabetes
DK149876C (da) Kobling til styring af driften af tandlaegers behandlingsinstrumenter
DE3788057D1 (de) Verwendung von heterocyclischen Verbindungen zur Behandlung von Depressionen.
DE3777861D1 (de) Behandlung von gasen.
DE3883606T2 (de) Verwendung von Fluoxetin zur Behandlung des Diabetes.
FI864570A0 (fi) Terapeutiskt anvaendbar foerening.
DK591787A (da) Anvendelse af 5-(substitueret phenyl)-oxa-zolidinonderivater til fremstilling af et til behandling af depressioner egnet laegemiddel
DE3774931D1 (de) Einrichtung zur gesteuerten waermebehandlung von weichenteilen.
ATE79255T1 (de) Wirkstoffe zur verhuetung von tumormetastasen.
ATE22800T1 (de) Verwendung von n-(diethylaminoethyl)-2-methoxy-5methylsulfonylbenzamiden zur hemmung von tryptophanepyrrolasen.
DE69131058D1 (de) Verwendung einer therapeutischen Zusammensetzung zur Behandlung von Bronchitis
NO862454L (no) Fremgangsmaate for behandling av peroxydblekeavluter.
DE3673072D1 (de) Behandlung von lignocellulosematerialien.
DE3684825D1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-amino-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.
ATE74334T1 (de) Behandlung von gasen.
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
ATE96667T1 (de) Verwendung von heterocyclischen verbindungen zur behandlung von depressionen.
ATE84435T1 (de) Einrichtung zur behandlung von gasen.
ATE46440T1 (de) Behandlung von praemenstruellen syndromen unter verwendung von triazolobenzodiazepinen.
PL200425A1 (pl) Sposob biologicznego oczyszczania sciekow
PL205035A1 (pl) Sposob oczyszczania sciekow osadem czynnym z zastosowaniem tlenu
ATE66780T1 (de) Zubereitung zur behandlung von psoriasis.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment